Suscribirse

BILIARY ATRESIA : A Surgical Perspective - 05/09/11

Doi : 10.1016/S1089-3261(05)70141-0 
Ryoji Ohi, MD *

Resumen

Case reports of infants with biliary atresia can be traced back to the nineteenth century.137, 138 In 1916, Holmes published a comprehensive review and stated that operative relief was theoretically possible in 60% of all cases.45 This article first introduced the concept of correctable and noncorrectable forms of biliary atresia. The first successful surgery for correctable biliary atresia was reported by Ladd in 1928.70 Of 11 patients on whom surgery was performed, 8 were amenable to surgical treatment, and 6 recovered. Several trials of surgical treatment of noncorrectable biliary atresia were attempted in the 1950s and early 1960s, with little improvement in patient outcome.2, 30, 88, 125, 128, 146 In 1957, Kasai et al reported surgical relief of biliary obstruction in infants traditionally considered to have noncorrectable biliary atresia by hepatic portal enterostomy.59, 60, 102

Although hepatic portoenterostomy became widely accepted in Japan, the early Western experience was controversial and occasionally emotional. Several pediatric surgeons would not recommend the procedure.17, 69 Conversely, confirmation of Kasai's results, albeit in small numbers of patients, was reported by Bill14 and by Lilly and Altman.74 In the 1980s all infants with biliary atresia born in Japan and 90% of the infants born elsewhere had the Kasai operation. The surgical results of patients in the Sendai series proved that performing the surgery early, before deterioration of the liver, is important for successful biliary drainage.97 At present, it is widely accepted that early diagnosis and timely surgery are indispensable to the successful management of children with biliary atresia. For children with a progressive clinical course after portal enterostomy, liver transplantation has become a viable therapeutic modality. This treatment was pioneered by Starzl in 1963124 and has evolved to include whole-organ and reduced-size liver transplantation, as well as living-related donor liver transplantation, which is now well established throughout the world and especially in Japan.105, 133

El texto completo de este artículo está disponible en PDF.

Esquema


 Address reprint requests to Ryoji Ohi, MD Department of Pediatric Surgery Tohoku University School of Medicine 1-1, Seiryomachi, Aobaku Sendai, 980 Japan


© 2000  W. B. Saunders Company. Publicado por Elsevier Masson SAS. Todos los derechos reservados.© 1997  © 1997 
Añadir a mi biblioteca Eliminar de mi biblioteca Imprimir
Exportación

    Exportación citas

  • Fichero

  • Contenido

Vol 4 - N° 4

P. 779-804 - novembre 2000 Regresar al número
Artículo precedente Artículo precedente
  • ALAGILLE SYNDROME : The Widening Spectrum of Arteriohepatic Dysplasia
  • Cécile Crosnier, Panayotis Lykavieris, Michèle Meunier-Rotival, Michelle Hadchouel
| Artículo siguiente Artículo siguiente
  • NONTRANSPLANT TREATMENT OF TYROSINEMIA
  • Elisabeth Holme, Sven Lindstedt

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.

¿Ya suscrito a @@106933@@ revista ?

@@150455@@ Voir plus

Mi cuenta


Declaración CNIL

EM-CONSULTE.COM se declara a la CNIL, la declaración N º 1286925.

En virtud de la Ley N º 78-17 del 6 de enero de 1978, relativa a las computadoras, archivos y libertades, usted tiene el derecho de oposición (art.26 de la ley), el acceso (art.34 a 38 Ley), y correcta (artículo 36 de la ley) los datos que le conciernen. Por lo tanto, usted puede pedir que se corrija, complementado, clarificado, actualizado o suprimido información sobre usted que son inexactos, incompletos, engañosos, obsoletos o cuya recogida o de conservación o uso está prohibido.
La información personal sobre los visitantes de nuestro sitio, incluyendo su identidad, son confidenciales.
El jefe del sitio en el honor se compromete a respetar la confidencialidad de los requisitos legales aplicables en Francia y no de revelar dicha información a terceros.


Todo el contenido en este sitio: Copyright © 2026 Elsevier, sus licenciantes y colaboradores. Se reservan todos los derechos, incluidos los de minería de texto y datos, entrenamiento de IA y tecnologías similares. Para todo el contenido de acceso abierto, se aplican los términos de licencia de Creative Commons.